FindTrial
Sign In

Effectiveness of intermittent Versus continuous phototherapy for jaundice in neonates more than 35 weeks of gestational age-A randomised controlled trial

Effectiveness of intermittent Versus continuous phototherapy for indirect hyperbilirubinemia in neonates more than 35 weeks of gestational age-A randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075529
Enrollment
156
Registered
2024-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P00-P96- Certain conditions originating in the perinatal period Health Condition 2: P84- Other problems with newborn

Interventions

Intervention1: Intermittent Phototherapy: 6 months 3 hours on and 3 hours off Intervention2: Intermittent phototherapy: 6 months Intervention3: Intermittent phototherapy: 3 6 months Control Interventi

Sponsors

Dr Namrata Kumari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All neonates with gestational age more than or equal to 35 weeks with non hemolytic hyperbilirubinemia

Exclusion criteria

Exclusion criteria: Hemolytic anemia Babies who are having congenital abnormalities Prematurity Birth asphyxia Assisted delivery Direct hyperbilirubinemia Onset of jaundice within first 24 hours of life Babies who are on ventilator Parents who are not willing

Design outcomes

Primary

MeasureTime frame
Measure rate of fall of bilirubin in two groupsTimepoint: At baseline,at end of study—

Secondary

MeasureTime frame
Compare duration of hospital stay among the groupsTimepoint: Six months—

Countries

India

Contacts

Public ContactNamrata Kumari

Chengalpattu Medical college and Hospital

drneomani@gmail.com9841781037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026